Trastuzumab Recruiting Phase 2 Trials for Stage IIB Breast Cancer / Stage IV Breast Cancer / Her2-Positive Breast Cancer / Inflammatory Breast Carcinoma / Stage IIA Breast Cancer / Recurrent Breast Cancer / Stage IIIC Breast Cancer / Stage IIIB Breast Cancer / Breast Adenocarcinoma / Stage IIIA Breast Cancer Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03094052Diarrhea Prophylaxis in Patients With HER2+ Breast Cancer Treated With Trastuzumab and Neratinib, Followed by Neratinib Monotherapy
NCT01730833Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer
NCT03125928Clinical Trial of Atezolizumab With Paclitaxel, Trastuzumab, and Pertuzumab in Patients With Metastatic HER-2 Positive Breast Cancer
NCT01873833Capecitabine, Cyclophosphamide, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With HER2-Positive Metastatic Breast Cancer